General & Plastic Surgery Devices - Lebanon

The General & Plastic Surgery Devices market market in Lebanon is forecasted to achieve a revenue of US$21.10m in 2024.
It is anticipated that the revenue will experience a compound annual growth rate (CAGR 2024-2029) of 2.99%, leading to a market volume of US$24.44m by 2029.
When compared on a global scale, the United States is expected to generate the highest revenue, amounting to US$9.84bn in 2024.
Lebanon's General & Plastic Surgery Devices market is witnessing a surge in demand for non-invasive procedures due to the increasing emphasis on natural-looking results.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Lebanon has witnessed significant growth in recent years, driven by customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Lebanon have played a crucial role in the development of the General & Plastic Surgery Devices market. Lebanese consumers have shown a growing inclination towards cosmetic procedures and enhancements, leading to an increased demand for plastic surgery devices. This preference can be attributed to various factors, including the influence of social media and celebrity culture, as well as the desire to enhance one's appearance and boost self-confidence. Trends in the market have also contributed to the growth of the General & Plastic Surgery Devices market in Lebanon. Technological advancements in surgical devices and procedures have made plastic surgery more accessible, safer, and less invasive. The introduction of innovative devices, such as laser-based systems and minimally invasive surgical instruments, has attracted both patients and healthcare professionals, driving market growth. Local special circumstances have further fueled the development of the General & Plastic Surgery Devices market in Lebanon. The country is known for its vibrant tourism industry, attracting visitors from around the world seeking medical treatments, including plastic surgery. Lebanon's reputation as a hub for medical tourism has created a favorable environment for the growth of the market, as it attracts both domestic and international patients. Underlying macroeconomic factors have also played a role in the growth of the General & Plastic Surgery Devices market in Lebanon. The country's improving economic conditions and rising disposable income levels have made cosmetic procedures more affordable for a larger segment of the population. Additionally, the presence of a well-established healthcare infrastructure and skilled medical professionals has instilled confidence in patients, further driving market growth. In conclusion, the General & Plastic Surgery Devices market in Lebanon has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As consumer demand for cosmetic procedures continues to rise and technological advancements in surgical devices progress, the market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.